Enavate Sciences GP, LLC
- SEC CIK
- 0001953107
- Latest filing
- Aug 14, 2026
CAMP holding history
Camp4 Therapeutics Corp in every 13F filed by Enavate Sciences GP, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CAMP overviewAll 13F holders of CAMPFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,425,541
- Value
- $6.23M
- % of portfolio
- 1.8%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,425,541 | $6.23M | 1.8% | −765,379−34.9% | Reduced | Holders |
| Q1 2026 | 2,190,920 | $9.66M | 2.7% | −844,905−27.8% | Reduced | Holders |
| Q4 2025 | 3,035,825 | $18.6M | 3.7% | −749,977−19.8% | Reduced | Holders |
| Q3 2025 | 3,785,802 | $11.4M | 3.5% | 00.0% | Unchanged | Holders |
| Q2 2025 | 3,785,802 | $5.49M | 3.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 3,785,802 | $15.1M | 11.4% | 00.0% | Unchanged | Holders |
| Q4 2024 | 3,785,802 | $19.8M | 14.2% | – | No prior filing | Holders |